Guotai Venture Capital

Guotai Venture Capital (国泰创投) is a Chinese venture capital firm whose portfolio skews toward healthcare and hard technology. The fund appears as a follow-on investor in at least two deals tracked by elsewhere: it participated in CAS-Ruiyi's (中科睿医) Series A round for intelligent neurological diagnosis and treatment infrastructure in 2023 , and was again listed among prior investors when the company raised a subsequent Series A+ in late 2024 . More recently, it joined the 420 million yuan angel+ round for Gestalt Technology (格式塔科技), a deal led by Huaying Capital and crowded with other top-tier names including Sequoia China and Innovation Works . The fund is also referenced as a co-investor alongside institutions such as C Capital, LanSi Technology, and Lingang Sci-Tech Investment in that same round. elsewhere's corpus does not contain founding-date, AUM, or team details for Guotai Venture Capital.